Krystal Biotech Announces Pricing of Upsized $125 Million Public Offering of Common Stock

Retrieved on: 2021-02-03 01:41:15

Tags for this article:

Click the tags to see associated articles and topics

Krystal Biotech Announces Pricing of Upsized $125 Million Public Offering of Common Stock. View article details on hiswai:

Excerpt

Goldman Sachs & Co. LLC, Cowen, and ... The offering is being made pursuant to a “shelf” registration statement on Form S-3 (File No. 333-237983) ...

Article found on: www.biospace.com